dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Vitiello, Pietro Paolo |
dc.contributor.author | Martini, Giulia |
dc.contributor.author | Ciardiello, Davide |
dc.contributor.author | Belli, Valentina |
dc.contributor.author | Matrone, Nunzia |
dc.contributor.author | Cardone, Claudia |
dc.date.accessioned | 2019-03-04T11:23:08Z |
dc.date.available | 2019-03-04T11:23:08Z |
dc.date.issued | 2019-01-28 |
dc.identifier.citation | Vitiello PP, Cardone C, Martini G, Ciardiello D, Belli V, Matrone N, et al. Receptor tyrosine kinase-dependent PI3K activation is an escape mechanism to vertical suppression of the EGFR/RAS/MAPK pathway in KRAS-mutated human colorectal cancer cell lines. J Exp Clin Cancer Res. 2019;38(1):41. |
dc.identifier.issn | 1756-9966 |
dc.identifier.uri | https://hdl.handle.net/11351/3831 |
dc.description | Càncer colorectal; Receptor epidèrmic de factor del creixement (EGFR); Via MAPK |
dc.language.iso | eng |
dc.publisher | BMC |
dc.relation.ispartofseries | Journal of Experimental and Clinical Cancer Research;38(1) |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ |
dc.source | Scientia |
dc.subject | Còlon - Càncer |
dc.subject | Factor de creixement epidèrmic - Inhibidors |
dc.subject | Proteïnes quinases activades per mitògens - Inhibidors |
dc.subject.mesh | Colorectal Neoplasms |
dc.subject.mesh | /microbiology |
dc.subject.mesh | Epidermal Growth Factor |
dc.subject.mesh | /antagonists & inhibitors |
dc.subject.mesh | MAP Kinase Kinase Kinases |
dc.subject.mesh | /antagonists & inhibitors |
dc.title | Receptor tyrosine kinase-dependent PI3K activation is an escape mechanism to vertical suppression of the EGFR/RAS/MAPK pathway in KRAS-mutated human colorectal cancer cell lines |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1186/s13046-019-1035-0 |
dc.subject.decs | neoplasias colorrectales |
dc.subject.decs | /microbiología |
dc.subject.decs | factor de crecimiento epidérmico |
dc.subject.decs | /antagonistas & inhibidores |
dc.subject.decs | MAP cinasa cinasa cinasas |
dc.subject.decs | /antagonistas & inhibidores |
dc.relation.publishversion | https://jeccr.biomedcentral.com/articles/10.1186/s13046-019-1035-0 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Vitiello PP, Cardone C] Department of Precision Medicine, Università degli studi della Campania "Luigi Vanvitelli", Naples, Italy. [Martini G] Department of Precision Medicine, Università degli studi della Campania "Luigi Vanvitelli", Naples, Italy. Vall d'Hebron Institut d'Oncologia, Barcelona, Spain. [Ciardiello D, Belli V, Matrone N] Department of Precision Medicine, Università degli studi della Campania "Luigi Vanvitelli", Naples, Italy. |
dc.identifier.pmid | 30691487 |
dc.identifier.wos | WOS:000458087900003 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |